Overview
Gilbert Bensimon practices in Nimes, France. Mr. Bensimon is rated as an Advanced expert by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Supranuclear Ophthalmoplegia, and Progressive Supranuclear Palsy.
His clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Progressive Supranuclear Palsy Atypical.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Brown SyndromeMr. Bensimon isAdvanced. Learn about Brown Syndrome.
- Primary Lateral SclerosisMr. Bensimon isAdvanced. Learn about Primary Lateral Sclerosis.
- Progressive Supranuclear PalsyMr. Bensimon isAdvanced. Learn about Progressive Supranuclear Palsy.
- Progressive Supranuclear Palsy Atypical
- Supranuclear OphthalmoplegiaMr. Bensimon isAdvanced. Learn about Supranuclear Ophthalmoplegia.
- Experienced
- Familial DysautonomiaMr. Bensimon isExperienced. Learn about Familial Dysautonomia.
- Movement DisordersMr. Bensimon isExperienced. Learn about Movement Disorders.
- Multiple System AtrophyMr. Bensimon isExperienced. Learn about Multiple System Atrophy.